Uses of Dovalga EF

What is Dovalga EF, is it a pain reliever and fever reducer? With main ingredients including Paracetamol and Tramadol, Dovalga EF has strong antipyretic and analgesic effects, used in the treatment of moderate to severe pain.

Dovalga EF belongs to the group of pain relievers and antipyretics, non-steroidal anti-inflammatory drugs, with the main ingredients being Paracetamol 325mg and Tramadol hydrochloride 37.5mg. Paracetamol has analgesic and antipyretic effects similar to Aspirin and can be used to replace Aspirin, but has no anti-inflammatory effect. Tramadol has a central analgesic effect.
Dovalga EF is formulated in the form of effervescent tablets and is indicated for the treatment of moderate to severe pain.

Dovalga EF is used orally, put the drug in water, wait for the drug to effervescent completely and then drink. Medicines can be taken outside of meals.
Dovalga EF dosage for children from 12 years old and adults (including elderly people over 65 years old) is usually 1-2 tablets / time, each time is taken 4-6 hours apart but should not exceed 8 tablets / day. Children under 12 years old should not take the drug
Overdosage of Dovalga EF may cause symptoms of Paracetamol and Tramadol poisoning, specifically:
Paracetamol overdose: Causes liver toxicity with manifestations such as irritability, sadness vomiting, vomiting, loss of appetite, gastrointestinal irritation, sweating, pale skin. These symptoms may occur 48 to 72 hours after taking the drug. Tramadol Overdose: An overdose of Dovalga EF including an overdose of Tramadol can cause serious damage such as respiratory failure, convulsions, coma, cardiac arrest, the end result can be death. Therefore, Dovalga EF should not be overdosed or used together with other drugs containing Paracetamol because it also leads to paracetamol overdose.

Dovalga EF medicine can cause some unwanted side effects with the frequency of occurrence as follows
Common: Nausea, drowsiness, dizziness, dizziness. Uncommon: Headache, abdominal pain, nausea, diarrhea, constipation, dry mouth, anorexia, flatulence, dyspepsia, fatigue, asthenia, emotional, insomnia, anxiety, restlessness, irritability likes, confusion, skin rash, itching, sweating. Rare: Dovalga EF rarely causes serious side effects such as increased or decreased blood pressure, chest pain, palpitations, tachycardia, cardiac arrhythmias; fainting, chills, withdrawal syndrome, tinnitus, dizziness, loss of balance, migraine, muscle tension, muscle spasms, convulsions, paresthesias; Tongue edema, dysphagia, black stools, gastrointestinal bleeding. Dovalga EF has rarely caused weight loss, liver test abnormalities, depression, hallucinations, nightmares, loss of consciousness, forgetfulness, impotence, mood swings, drug abuse; shortness of breath, anemia; urinary disorders, urinary retention, oliguria, albuminuria; vision disturbance. If you see any abnormal symptoms after taking Dovalga EF, the patient should immediately report it to a doctor or soon go to a medical facility for examination and health check.

Do not use Dovalga EF in people with hypersensitivity to the ingredients of the drug, women who are breastfeeding. Do not drive or operate or operate machinery while taking this medicine, as Dovalga EF may cause dizziness. Concomitant administration of Dovalga EF with SSRIs, tricyclic antidepressants, opioids, MAOIs, sedatives or drugs that lower the seizure threshold may increase the risk of seizures. People with epilepsy, history or risk factors for convulsions should use caution when taking Dovalga EF because it also increases the risk of seizures. Use of high doses of Dovalga EF together with alcohol, anesthetics, local anesthetics or people with risk factors for respiratory depression should be used with caution. People with head injury, increased intracranial pressure should be careful when using Dovalga EF. Opium addicts taking Dovalga EF may relapse, chronic alcoholics taking the drug may experience liver toxicity. In the treatment of Dovalga EF overdose, caution should be exercised when using Naloxone because of the possible increased risk of convulsions. Patients with renal failure with creatinine clearance less than 30ml/min should not take more than 2 Dovalga EF tablets/day, 12 hours apart. People with severe liver failure need to be careful when using the drug. Concomitant administration of Dovalga EF with Carbamazepine may increase the metabolism of Tramadol and lead to a decrease in its analgesic effect. Concomitant administration of Dovalga EF with Quinidine may increase the concentration of Tramadol; with substances of the group Warfarin can increase the blood-clotting effect; with CYP2D6 inhibitors may limit the metabolism of Tramadol. The use of Dovalga EF is to relieve pain and reduce fever, especially for moderate to severe pain relief due to the combination of Tramadol and Paracetamol. To ensure safety for your health and maximize the effectiveness of your treatment, you need to take Dovalga EF exactly as directed by your doctor.